Breast Cancer Clinical Trial
Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
Summary
There is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort. The purpose of this investigation is to aggregate data from multiple institutions to describe the risk, diagnosis, management, and outcomes of TGD persons with breast cancer in effort to identify opportunities for future intervention studies to eliminate breast cancer disparities for this population.
Eligibility Criteria
Inclusion Criteria:
Age 18 years of age or older
Breast cancer diagnosis (including DCIS)
Persons who identify as gender and/or sex that is different from the sex they were assigned at birth
Exclusion Criteria:
Age <18 at time of breast cancer diagnosis
Cis-gendered persons
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 16 Locations for this study
San Francisco California, 94115, United States
Aurora Colorado, 80045, United States
Jacksonville Florida, 32224, United States
Tampa Florida, 33612, United States
Chicago Illinois, 60611, United States
Chicago Illinois, 60612, United States
Evanston Illinois, 60201, United States
Boston Massachusetts, 02118, United States
Ann Arbor Michigan, 48109, United States
Rochester Minnesota, 55905, United States
Rochester New York, 14623, United States
Durham North Carolina, 27710, United States
Cincinnati Ohio, 45221, United States
Philadelphia Pennsylvania, 19111, United States
Seattle Washington, 98195, United States
Milwaukee Wisconsin, 53226, United States
How clear is this clinincal trial information?